UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Menopausal status and adjuvant hormonal therapy for breast cancer patients: A practical guideline

Critical reviews in oncology/hematology, 2012-11, Vol.84 (2), p.252-260

2012

Volltextzugriff (PDF)

Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors

Critical reviews in oncology/hematology, 2010-11, Vol.76 (2), p.133-141

2010

Volltextzugriff (PDF)

Heterozygosity for a point mutation in an invariant splice donor site of dihydropyrimidine dehydrogenase and severe 5-fluorouracil related toxicity

European journal of cancer (1990), 1997-11, Vol.33 (13), p.2258-2264

1997

Volltextzugriff (PDF)

Timely withdrawal of G-CSF reduces the occurrence of thrombocytopenia during dose-dense chemotherapy

Breast cancer research and treatment, 2005-09, Vol.93 (2), p.117-123

2005

Volltextzugriff (PDF)

Repeated mammographic screening reduces breast cancer mortality along the continuum of age

Journal of medical screening, 2002-01, Vol.9 (4), p.163-167

2002

Volltextzugriff (PDF)

In primary breast cancer the mitotic activity yields similar prognostic information as the histological grade: a study with long-term follow-up

Breast cancer research and treatment, 2010-07, Vol.122 (1), p.77-86

2010

Volltextzugriff (PDF)

Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial

Annals of oncology, 2010-05, Vol.21 (5), p.974-982

2010

Volltextzugriff (PDF)

In Reply

Journal of clinical oncology, 2005-05, Vol.23 (13), p.3160-3161

2005

Volltextzugriff (PDF)

Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients: clinical outcomes and oncologists’ preferences

European journal of cancer (1990), 2003-03, Vol.39 (5), p.614-621

2003

Volltextzugriff (PDF)

Cost-effectiveness of new guidelines for adjuvant systemic therapy for patients with primary breast cancer

Annals of oncology, 2005-12, Vol.16 (12), p.1874-1881

2005

Volltextzugriff (PDF)

Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance

European Journal of Cancer, 1998-10, Vol.34 (11), p.1677-1682

1998

Volltextzugriff (PDF)

Adherence to the guidelines of the CCCE in the treatment of node-positive breast cancer patients

European journal of cancer (1990), 2004-01, Vol.40 (2), p.198-204

2004

Volltextzugriff (PDF)

The prognostic value of the mitotic activity index in patients with primary breast cancer who were not treated with adjuvant systemic therapy

Breast cancer research and treatment, 2003, Vol.77 (1), p.77-84

2003

Volltextzugriff (PDF)

Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients

European journal of cancer (1990), 2003-03, Vol.39 (5), p.614-621

2003

Volltextzugriff (PDF)

Does supportive pamidronate treatment prevent or delay the first manifestation of bone metastases in breast cancer patients?

European journal of cancer (1990), 1996-03, Vol.32 (3), p.450-454

1996

Volltextzugriff (PDF)

Quality of adjuvant chemotherapy in primary breast cancer in a non-trial setting. A comprehensive cancer centre study

European journal of cancer (1990), 1999-03, Vol.35 (3), p.386-391

1999

Volltextzugriff (PDF)

High-dose chemotherapy in breast cancer. The Dutch trial

European journal of cancer (1990), 2001-04, Vol.37, p.S285-S285

2001

Volltextzugriff (PDF)

REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENT

The Lancet (British edition), 1987-10, Vol.330 (8566), p.983-985

1987

Volltextzugriff (PDF)

CMF and mitoxantrone in elderly patients with advanced breast cancer. A randomized phase II study

European journal of cancer (1990), 1998-09, Vol.34, p.S91-S91

1998

Volltextzugriff (PDF)

Breast cancer, trends in research and treatment

European journal of obstetrics & gynecology and reproductive biology, 1977-01, Vol.7 (3), p.215-216

Beex, L.V.A.M.

1977

Volltextzugriff (PDF)

Heterozygosity for a point mutation in an invariant splice donor site of dihydropyrimidine dehydrogenase and severe 5-fluorouracil related toxicity

Clinical biochemistry, 1997-04, Vol.30 (3), p.290-290

1997

Volltextzugriff (PDF)

Epidermal growth factor receptors in human breast cancer: a plea for standardisation of assay methodology

European journal of cancer (1990), 1992, Vol.28 (2), p.693-697

1992

Volltextzugriff (PDF)

Breast cancer, molecular genetics, pathogenesis and therapeutics

European Journal of Obstetrics and Gynecology, 2000, Vol.89 (2), p.221-222

Beex, L.V.A.M

2000

Volltextzugriff (PDF)

Dose intensity of chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil in the elderly with advanced breast cancer

European journal of cancer (1990), 1992, Vol.28 (2), p.686-690

1992

Volltextzugriff (PDF)

Short versus long term treatment with CMF in posthemopausal patients with advanced breast cancer; an eortc breast cancer co-operative group phase III trial (10852)

European journal of cancer (1990), 1993, Vol.29, p.S77-S77

1993

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(34)
Reviews
(2)

Sprache

Englisch
(36)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Female
(18)
Humans
(18)
Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Oncology
(16)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Middle Aged
(14)
Aged
(13)
Breast Cancer
(12)
Gynecology. Andrology. Obstetrics
(11)
Mammary Gland Diseases
(11)
Tumors
(11)
Adult
(10)
Aged, 80 And Over
(10)
Breast Neoplasms - Drug Therapy
(9)
Pharmacology. Drug Treatments
(8)
Breast Neoplasms - Pathology
(7)
Antineoplastic Agents
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Menopausal status and adjuvant hormonal therapy for breast cancer patients: A practical guideline

Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors

Heterozygosity for a point mutation in an invariant splice donor site of dihydropyrimidine dehydrogenase and severe 5-fluorouracil related toxicity

Timely withdrawal of G-CSF reduces the occurrence of thrombocytopenia during dose-dense chemotherapy

Repeated mammographic screening reduces breast cancer mortality along the continuum of age

In primary breast cancer the mitotic activity yields similar prognostic information as the histological grade: a study with long-term follow-up

Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial

In Reply

Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients: clinical outcomes and oncologists’ preferences

Cost-effectiveness of new guidelines for adjuvant systemic therapy for patients with primary breast cancer

Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance

Adherence to the guidelines of the CCCE in the treatment of node-positive breast cancer patients

The prognostic value of the mitotic activity index in patients with primary breast cancer who were not treated with adjuvant systemic therapy

Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients

Does supportive pamidronate treatment prevent or delay the first manifestation of bone metastases in breast cancer patients?

Quality of adjuvant chemotherapy in primary breast cancer in a non-trial setting. A comprehensive cancer centre study

High-dose chemotherapy in breast cancer. The Dutch trial

REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENT

CMF and mitoxantrone in elderly patients with advanced breast cancer. A randomized phase II study

Breast cancer, trends in research and treatment

Heterozygosity for a point mutation in an invariant splice donor site of dihydropyrimidine dehydrogenase and severe 5-fluorouracil related toxicity

Epidermal growth factor receptors in human breast cancer: a plea for standardisation of assay methodology

Breast cancer, molecular genetics, pathogenesis and therapeutics

Dose intensity of chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil in the elderly with advanced breast cancer

Short versus long term treatment with CMF in posthemopausal patients with advanced breast cancer; an eortc breast cancer co-operative group phase III trial (10852)

Suchergebnisse filtern